olmesartan has been researched along with fumarates in 11 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (fumarates) | Trials (fumarates) | Recent Studies (post-2010) (fumarates) |
---|---|---|---|---|---|
841 | 185 | 554 | 4,655 | 342 | 1,823 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 10 (90.91) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Celi, A; Cianchetti, S; Del Fiorentino, A; Pedrinelli, R | 1 |
Amaha, M; Kawagoe, Y; Maeda, S; Nakamura, T; Sato, E; Yamagishi, S | 1 |
Axthelm, C; Kaiser, E; Meister, F; Sieder, C | 1 |
Akarte, AS; Gandhi, S; Srinivasan, BP | 1 |
Kumagai, H; Matsubara, H; Oda, T; Ohshima, N; Senda, M; Tadano, H; Takechi, H; Uchida, T; Watanabe, A; Yamamoto, K | 1 |
Barrios, V; Escobar, C | 1 |
Al-Harbi, MM; Al-Harbi, NO; Al-Hosaini, KA; Bahashwan, S; Imam, F; Iqbal, M; Nadeem, A; Rahman, S | 1 |
di Mario, C; Francis, DP; Hayward, C; Krum, H; Lyon, AR; Ozdemir, BA; Patel, HC; Rosen, SD | 1 |
Chang, TT; Chen, JS; Chen, JW; Huang, PH; Lin, LY; Lin, SJ; Wu, TC | 1 |
Bhosale, V; Hanif, K; Jagavelu, K; Jain, M; Pal, N; Singh, H; Tripathi, D | 1 |
Guo, S; Jiang, F; Kim, GJ; Melgoza, A | 1 |
3 review(s) available for olmesartan and fumarates
Article | Year |
---|---|
[Recent advance in kidney and hypertension research].
Topics: Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Calcium Channel Agonists; Catheter Ablation; Cerebrovascular Circulation; Chronic Disease; Diabetic Nephropathies; Drug Therapy, Combination; Evidence-Based Medicine; Fumarates; Humans; Hypertension; Imidazoles; Kidney; Kidney Diseases; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2012 |
An evaluation of the latest evidence relating to renin-angiotensin system inhibitors.
Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Fumarates; Humans; Imidazoles; Meta-Analysis as Topic; Neoplasms; Oxadiazoles; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Telmisartan; Tetrazoles | 2013 |
Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation.
Topics: Amides; Antihypertensive Agents; Benzimidazoles; Benzopyrans; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Control Groups; Double-Blind Method; Drug Resistance; Eplerenone; Ethanolamines; Fumarates; Humans; Hypertension; Imidazoles; Kidney; Nebivolol; Oxadiazoles; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Spironolactone; Sympathectomy; Tetrazoles; Treatment Outcome | 2015 |
2 trial(s) available for olmesartan and fumarates
Article | Year |
---|---|
Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria.
Topics: Adult; Amides; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Fatty Acid-Binding Proteins; Female; Fumarates; Humans; Imidazoles; Kidney Failure, Chronic; Kidney Tubules; Male; Proteinuria; Regression Analysis; Tetrazoles | 2012 |
Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amides; Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Resistance; Drug Substitution; Female; Fumarates; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tablets; Tetrazoles; Treatment Failure; Treatment Outcome; Young Adult | 2012 |
6 other study(ies) available for olmesartan and fumarates
Article | Year |
---|---|
Aliskiren, a renin inhibitor, downregulates TNF-α-induced tissue factor expression in HUVECS.
Topics: Amides; Captopril; Down-Regulation; Endothelial Cells; Fumarates; Humans; Imidazoles; Renin; Tetrazoles; Thromboplastin; Tumor Necrosis Factor-alpha; Umbilical Veins | 2010 |
Effective blockade of RAAS by combination of aliskiren and olmesartan improves glucose homeostasis, glomerular filtration rate along with renal variables in streptozotocin induced diabetic rats.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Fumarates; Glomerular Filtration Rate; Glucose Transporter Type 2; Glucose Transporter Type 4; Humans; Imidazoles; Insulin; Kidney; Liver; Muscle, Skeletal; Rats; Rats, Wistar; Renin-Angiotensin System; Serum Albumin; Tetrazoles; Time Factors | 2012 |
Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren.
Topics: Amides; Animals; Fumarates; Heart; Imidazoles; Immunosuppressive Agents; Male; Myocardium; Rats; Rats, Wistar; Tacrolimus; Tetrazoles | 2014 |
Aliskiren directly improves endothelial progenitor cell function from Type II diabetic patients.
Topics: Amides; Antihypertensive Agents; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Diabetes Mellitus, Type 2; Endothelial Progenitor Cells; Fumarates; Humans; Hydralazine; Imidazoles; In Vitro Techniques; Nitric Oxide Synthase Type III; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tetrazoles; Vascular Endothelial Growth Factor A | 2016 |
Antihypertensive Drugs Aliskiren, Nebivolol, and Olmesartan Reduce Hypertension by Reducing Endothelial Microparticles and Regulating Angiogenesis.
Topics: Amides; Animals; Antihypertensive Agents; Cell-Derived Microparticles; Drug Therapy, Combination; Fumarates; Humans; Hypertension; Imidazoles; Male; Nebivolol; Neovascularization, Pathologic; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles | 2017 |
The effect of renin-angiotensin-aldosterone system inhibitors on organ-specific ace2 expression in zebrafish and its implications for COVID-19.
Topics: Amides; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; COVID-19; Down-Regulation; Fumarates; Gills; Humans; Imidazoles; Liver; Models, Animal; SARS-CoV-2; Tetrazoles; Up-Regulation; Zebrafish | 2021 |